Entrar/Registro  
HOME SPANISH
 
Revista Cubana de Medicina
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Revista Cubana de Medicina >Year 2014, Issue 3


Álvarez AA, González AJC, Maceo GLR, Frómeta GA, Bárzaga MS, Cervantes IAE
Prediction tree for hypertensive heart disease
Rev cubana med 2014; 53 (3)

Language: Español
References: 31
Page: 266-281
PDF: 469.38 Kb.


Full text




ABSTRACT

Introduction: hypertensive heart disease is associated with high morbidity and mortality. The complexity of its prevention lies in the number of risk factors involved in its development.
Objective: design and validate a prediction tree for the development of hypertensive heart disease on the basis of hemodynamic and non-hemodynamic factors.
Methods: a prediction tree for the development of hypertensive heart disease was designed and validated following the procedure of knowledge discovery in databases and data mining. The patients surveyed were being cared for at the hypertension specialized consultation of the secondary care polyclinic in Carlos Manuel de Céspedes General University Hospital, municipality of Bayamo, Granma province, Cuba, from 1 January 2004 to 31 December 2009.
Results: the tree predicted risk of developing hypertensive heart disease in 82.598% of the patients, with an area of 0.861 under the ROC curve and a true positives rate of 0.733 and 0.921 for classes 1 and 2, respectively. The most important factor was C-reactive protein, followed by glycemia, uric acid, cholesterol and microalbuminuria, in that order.
Conclusions: the decision making tree and the set of rules deriving from it allowed prediction of the risk to develop hypertensive heart disease in high blood pressure patients. Their incorporation into clinical practice will improve the evaluation of these patients.


Key words: hypertensive heart disease, arterial hypertension, risk factors, prediction tree.


REFERENCIAS

  1. The Seventh Report of the Joint National Comitte on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA [Internet]. 2003 [citado 15 May 2004];289(19):2560-71. Disponible en: http://jama.jamanetwork.com/article.aspx?articleid=185953

  2. Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial SEH-LELHA. Guía sobre el diagnóstico y el tratamiento de la hipertensión arterial en España 2005. Hipertensión [Internet]. 2005 [citado 12 Abr 2007];22(Supl 2):1-84. Disponible en: http://www.seh.lelha.org/guia05.htm

  3. Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res [Internet]. 2005 [citado 15 May 2007];28:191-202. Disponible en: http://www.nature.com/hr/journal/v28/n3/pdf/hr200525a.pdf

  4. Mitchell JA, Ventura HO, Mehra MR. Early recognition and treatment of hypertensive heart disease. Curr Opin Cardiol. 2005;20:282-9.

  5. López B, González A, Querejeta R, Díez J. The use of collagenderived serum peptides for the clinical assessment of hypertensive heart disease. J Hypertens. 2005;23:1445-51.

  6. Díez J, Frohlich ED. A translational approach to hypertensive heart disease. Hypertension [Internet]. 2010 [citado 29 Feb 2010];55:1-8. Disponible en: http://hyper.ahajournals.org/content/55/1/1

  7. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA [Internet]. 2010 [citado 21 Ene 2011];303(20):2043-50. Disponible en: http://jama.jamanetwork.com/article.aspx?articleid=185953

  8. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burniere M, Caulfieldf MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens [Internet]. 2009 [citado 30 Feb 2010];27(11):1-38. Disponible en: http://www.ish.org.il/2009GuidelinesESH.pdf

  9. Tousoulis D, Koumallos N, Antoniades C, Antonopoulos AS, Bakogiannis B, Milliou A, et al. Genetic polymorphism on type 2 receptor of angiotensin II, modifies cardiovascular risk and systemic inflammation in hypertensive males. Am J Hypertens [Internet]. 2010 [citado 14 Dic 2010];23:237-42. Disponible en: http://ajh.oxfordjournals.org/content/23/3/237.full

  10. García Barreto D, Álvarez González J, García Fernández R, Valiente Mustelier J, Hernández Cañero A. La hipertensión arterial en la tercera edad. Rev Cubana Med [Internet]. 2009 Jun [citado 20 Ago 2010];48(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75232009000200007&lng=es&nrm=iso&tlng=es

  11. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens [Internet]. 2007 [citado 16 May 2008];25:1105-87. Disponible en: http://www.escardio.org/guidelines-surveys/escguidelines/ GuidelinesDocuments/guidelines-AH-FT.pdf

  12. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation [Internet].1977 [citado 13 Ene 2004];55:613-8. Disponible en: http://circ.ahajournals.org/content/55/4/613.long

  13. Graf K, Schaefer-Graf UM. Is Smad3 the key to inflammation and fibrosis in hypertensive heart disease?Hypertension [Internet]. 2010 [citado 28 Ene 2011];55:1088-9. Disponible en: http://hyper.ahajournals.org/content/55/5/1088.long

  14. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas Heart Study. Circ Cardiovasc Imaging [Internet]. 2010 [citado 28 Nov 2010];3:164-71. Disponible en: http://circimaging.ahajournals.org/content/3/2/164.full.pdf

  15. Beaumont J, Arias T, López B, González A, Ravassa S, Hermida N, et al. Avances en cardiopatía hipertensiva. Mecanismos de remodelado implicados en la transición de la hipertrofia a la insuficiencia cardíaca. Rev Esp Cardiol [Internet]. 2007 [citado 31 Mar 2009];7(Supl):14F-21F. Disponible en: http://www.revespcardiol.org/es/avances-cardiopatia-hipertensiva-mecanismosremodelado/ articulo/13110828/

  16. Drazner MH. The Progression of Hypertensive Heart Disease. Circulation [Internet]. 2011 [citado 16 May 2011];123:327-34. Disponible en: http://circ.ahajournals.org/content/123/3/327.long

  17. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol [Internet]. 2011 [citado 15 Mar 2011];123:104-23. Disponible en: http://circ.ahajournals.org/content/123/1/104.full

  18. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest [Internet]. 2003;111(12):1805-12. [citado 15 Mar 2004] Disponible en: http://www.jci.org/articles/view/18921 doi 10.1172/JCI18921

  19. MICROALBUMIN Latex L. Quantitative turbidimetric latex assay for the measurement of Microalbumin in human urine. [Internet]. 1996 [citado 12 May 2003]. Disponible en: http://www.gdsrl.com/upload/prodotti/gd8439_00_microalbumin_1.pdf

  20. Reyes Saldaña JF, García Flores R. Descubrimiento de conocimientos en bases de datos. Ingenierías [Internet]. 2005 [citado 25 Ene 2009];8(26):37-47. Disponible en:http://ocw.univalle.edu.co/ocw/ingenieria-de-sistemas-telematica-yafines/ descubrimiento-de-conocimiento-en-bases-de-datos/Course_listing

  21. Alonso C. WEKA: Waitako Environment for Knowledge Analysis. Introducción básica. Departamento de Informática Universidad de Valladolid. [Internet]. 2006 [citado 27 Ago 2009]. Disponible en: http://www.infor.uva.es/~calonso/IAII/Aprendizaje/weka/IntroduccionWeka.pdf

  22. Pérez Caballero MD, Dueñas Herrera A, Alfonso Guerra JP, Vázquez Vigoa A, Navarro Despaigne D, Hernández Cueto M, et al. Hipertensión arterial. Guía para la prevención, diagnóstico y tratamiento. Comisión Nacional Técnica Asesora del Programa de Hipertensión Arterial. La Habana: Editorial Ciencias Médicas; 2008.

  23. D'Agostino RB, Grundy S, Sullivan LM, Wilson P, for the CHD Risk Prediction Group. Validation of the Framingham Coronary Heart Disease Prediction Scores. Results of a multiple ethnic groups investigation. JAMA [Internet]. 2001[citado 14 Ene 2007];286:180-7. Disponible en: http://jama.jamanetwork.com/article.aspx?articleid=193997

  24. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovás J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol [Internet]. 2003 [citado 14 Ene 2007];56(3):253-61. Disponible en: http://www.revespcardiol.org/es/estimacion-del-riesgo-coronarioespana/ articulo/13043951/

  25. Marshall T. The effect of blood pressure and cholesterol variability on the precision of Framingham cardiovascular risk estimation: a simulation study. J Hum Hypertens [Internet]. 2010 [citado 18 Ene 2011];24:1-8. Disponible en: http://www.nature.com/jhh/journal/v24/n10/full/jhh2009114a.html

  26. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to the cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart [Internet]. 2007 [citado 26 Dic 2007];2:172-6. Disponible en: http://heart.bmj.com/content/93/2/172.long

  27. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ [Internet]. 2007 [citado 26 Dic 2007];335:136-41. Disponible en: http://www.bmj.com/content/335/7611/136

  28. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care the Framingham heart study. Circulation [Internet]. 2008 [citado 26 Jun 2009];117:743-53. Disponible en: http://circ.ahajournals.org/content/117/6/743.long

  29. Baena-Díez JM, Ramos R, Marrug J. Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades. Rev Esp Cardiol [Internet]. 2009 [citado 25 Ago 2010];9(Supl):4B-13B. Disponible en: http://www.revespcardiol.org/es/capacidad-predictiva-las-funcionesriesgo/ articulo/13137261/

  30. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ [Internet]. 2007 [citado 26 Dic 2011];335:136-41. Disponible en: http://www.bmj.com/content/335/7611/136

  31. Buitrago F, Cañón-Barroso L, Díaz-Herrera N, Cruces-Muro E, Escobar- Fernández M, Serrano-Arias JM. Comparación de las tablas REGICOR y SCORE para la clasificación del riesgo cardiovascular y la identificación de pacientes candidatos a tratamiento hipolipemiante o antihipertensivo. Rev Esp Cardiol. [Internet]. 2007 [citado 28 Feb 2009];60:139-47. Disponible en: http://www.revespcardiol.org/es/comparacion-las-tablas-regicorscore/ articulo/13099460/






>Journals >Revista Cubana de Medicina >Year 2014, Issue 3
 

· Journal Index 
· Links 






       
Copyright 2019